GSEP
Golden State Equity Partners Portfolio holdings
AUM
$540M
1-Year Return
21.96%
This Quarter Return
+7.65%
1 Year Return
+21.96%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$190M
AUM Growth
-$290M
(-60%)
Cap. Flow
-$314M
Cap. Flow
% of AUM
-165.08%
Top 10 Holdings %
Top 10 Hldgs %
31.39%
Holding
921
New
505
Increased
48
Reduced
253
Closed
104
Top Buys
Top Sells
| 1 |
NVIDIA
NVDA
|
$28.7M |
| 2 |
Apple
AAPL
|
$24.4M |
| 3 |
Microsoft
MSFT
|
$15M |
| 4 |
SPDR Portfolio S&P 500 ETF
SPLG
|
$8.47M |
| 5 |
Amazon
AMZN
|
$7.11M |
Sector Composition
| 1 | Technology | 9% |
| 2 | Industrials | 7.49% |
| 3 | Financials | 7.44% |
| 4 | Consumer Discretionary | 5.26% |
| 5 | Healthcare | 3.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
451
Exponent
EXPO
$3.61B
| $31.6K | 0.02% |
+274
| New | +$31.6K |
|
|
PROF
452
Profound Medical
PROF
$124M
| $31.5K | 0.02% |
+3,961
| New | +$31.5K |
|
453
West Pharmaceutical
WST
$18B
| $31.5K | 0.02% |
105
-1,130
| -91% | -$339K |
|
454
Harley-Davidson
HOG
$3.67B
| $31.4K | 0.02% |
+815
| New | +$31.4K |
|
455
Altria Group
MO
$112B
| $31.1K | 0.02% |
610
-10,248
| -94% | -$523K |
|
456
NetApp
NTAP
$23.7B
| $30.9K | 0.02% |
+250
| New | +$30.9K |
|
457
Otis Worldwide
OTIS
$34.1B
| $30.7K | 0.02% |
+295
| New | +$30.7K |
|
458
Teledyne Technologies
TDY
$25.7B
| $30.6K | 0.02% |
+70
| New | +$30.6K |
|
459
iShares S&P Mid-Cap 400 Growth ETF
IJK
$9.22B
| $30.3K | 0.02% |
+330
| New | +$30.3K |
|
460
Apellis Pharmaceuticals
APLS
$3.55B
| $30.3K | 0.02% |
+1,050
| New | +$30.3K |
|
461
Saia
SAIA
$8.34B
| $30.2K | 0.02% |
+69
| New | +$30.2K |
|
462
Neurocrine Biosciences
NBIX
$14.3B
| $30K | 0.02% |
+260
| New | +$30K |
|
463
EQT Corp
EQT
$32.2B
| $29.9K | 0.02% |
+815
| New | +$29.9K |
|
464
Airbnb
ABNB
$75.8B
| $29.7K | 0.02% |
+234
| New | +$29.7K |
|
465
Tarsus Pharmaceuticals
TARS
$2.43B
| $29.6K | 0.02% |
+900
| New | +$29.6K |
|
466
Carrier Global
CARR
$55.8B
| $29.2K | 0.02% |
+363
| New | +$29.2K |
|
467
Enphase Energy
ENPH
$5.18B
| $29.2K | 0.02% |
258
-3,176
| -92% | -$359K |
|
468
Plains GP Holdings
PAGP
$3.64B
| $28.4K | 0.01% |
1,533
-8,702
| -85% | -$161K |
|
469
Ocular Therapeutix
OCUL
$2.37B
| $28.3K | 0.01% |
+3,250
| New | +$28.3K |
|
470
Verisk Analytics
VRSK
$37.8B
| $28.1K | 0.01% |
+105
| New | +$28.1K |
|
471
Xylem
XYL
$34.2B
| $27.9K | 0.01% |
+207
| New | +$27.9K |
|
|
CNTA
472
Centessa Pharmaceuticals
CNTA
$2.11B
| $27.2K | 0.01% |
+1,700
| New | +$27.2K |
|
473
Dynatrace
DT
$15.1B
| $27K | 0.01% |
+505
| New | +$27K |
|
474
CrowdStrike
CRWD
$105B
| $26.9K | 0.01% |
96
-1,150
| -92% | -$323K |
|
475
KeyCorp
KEY
$20.8B
| $26.9K | 0.01% |
+1,606
| New | +$26.9K |
|